Today: 22 December 2025
Subscribe
Browse Category

NYSE:NVS News 27 June 2025 - 21 December 2025

AbbVie Stock Week Ahead (Dec. 22–26, 2025): ABBV Holds Near $227 as Drug-Pricing Headlines Collide With Fresh Analyst Upgrades

AbbVie Stock Week Ahead (Dec. 22–26, 2025): ABBV Holds Near $227 as Drug-Pricing Headlines Collide With Fresh Analyst Upgrades

As of Sunday, December 21, 2025, AbbVie Inc. (NYSE: ABBV) heads into a holiday-shortened trading week with shares hovering near the mid-$220s, after a high-volume rebound into Friday’s close. The setup for the week ahead is defined by two competing
21 December 2025
 ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  · 
Pharma Stocks Week Ahead (Dec. 22–26, 2025): Drug-Pricing Deals, FDA Catalysts, and M&A to Watch

Pharma Stocks Week Ahead (Dec. 22–26, 2025): Drug-Pricing Deals, FDA Catalysts, and M&A to Watch

Christmas week is usually about thin liquidity and shorter trading hours, not blockbuster headlines. But pharma and biotech stocks head into the final full week of the year with a rare mix of policy shockwaves, deal-making, and FDA-driven volatility—all clustered
21 December 2025
 ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  · 
Healthcare Stocks News Today: Drug Pricing Shake-Up, Biotech M&A, IPO Momentum, and 2026 Outlook (Dec. 20, 2025)

Healthcare Stocks News Today: Drug Pricing Shake-Up, Biotech M&A, IPO Momentum, and 2026 Outlook (Dec. 20, 2025)

As of December 20, 2025, healthcare stocks are heading into year-end with a rare mix of policy clarity and policy risk—often at the same time. In the past 48 hours, the sector has been hit by major U.S. drug-pricing announcements,
20 December 2025
 ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  · 
Salesforce (CRM) Stock After Hours Today (Dec. 17, 2025): Qualified Acquisition, Novartis Agentforce Deal, Analyst Forecasts, and What to Watch Before the Market Opens

Salesforce (CRM) Stock After Hours Today (Dec. 17, 2025): Qualified Acquisition, Novartis Agentforce Deal, Analyst Forecasts, and What to Watch Before the Market Opens

Salesforce, Inc. (NYSE: CRM) ended Wednesday, December 17, 2025, on a relative high in a tough tape—then edged lower in after-hours trading as investors processed late-day headlines and looked ahead to a potentially market-moving inflation print Thursday morning. Salesforce stock
18 December 2025
 ·  ·  ·  ·  ·  · 
Swiss Stock Market Today, 26 November 2025: SMI Edges Higher as Sentiment Surges and Insurers Face Tougher Rules

Swiss Stock Market Today, 26 November 2025: SMI Edges Higher as Sentiment Surges and Insurers Face Tougher Rules

The Swiss stock market added another cautious step higher on Wednesday, 26 November 2025, extending a three‑day recovery but without anything resembling a full‑blown rally. The Swiss Market Index (SMI) closed at 12,781.09 points, up 0.07% from Tuesday’s finish of
26 November 2025
 ·  ·  ·  ·  ·  · 
uniQure (QURE) Stock Soars on Huntington’s Breakthrough – Key Facts & 2025 Outlook

A One‑Time Brain Gene Therapy Just Slowed Huntington’s by 75%—Is This the Turning Point Families Have Waited For?

Key facts (quick read) In‑depth report 1) Huntington’s disease, in plain English What it is. HD is a progressive brain disorder that typically begins in mid‑adulthood, causing a mix of movement (chorea, dystonia), cognitive (processing speed, executive function) and psychiatric symptoms
26 September 2025
 ·  ·  ·  ·  ·  ·  · 
Tariff Shocks & Rate Jitters Ignite Wild 48 Hours in European Markets

Tariff Shocks & Rate Jitters Ignite Wild 48 Hours in European Markets

Key Facts German DAX index graph at the Frankfurt Stock Exchange, reflecting volatile mid-week trading reuters.com. Pan-European Overview: From Slump to Rebound European equities seesawed over the two days, buffeted by transatlantic trade tensions and shifting rate expectations. On Thursday
26 September 2025
 ·  ·  ·  ·  ·  ·  · 
Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Richmond’s New Pharma Giant: Overview of Lilly’s $5B Factory Eli Lilly’s forthcoming Richmond-area factory is set to be one of the largest and most advanced pharmaceutical manufacturing sites in the world. At a cost of $5 billion, Lilly will construct
16 September 2025
 ·  ·  ·  ·  ·  ·  ·  ·  · 
Undersea Cable Chaos, iPhone 17 “Air” Reveal & $500B Cloud Bombshell – The Biggest Tech News (Sept 9–10, 2025)

Undersea Cable Chaos, iPhone 17 “Air” Reveal & $500B Cloud Bombshell – The Biggest Tech News (Sept 9–10, 2025)

Consumer Electronics: Apple Unveils Ultra-Thin iPhone 17 Air and More Apple’s latest devices on display at the September 9 launch event in Cupertino. Apple introduced its 2025 lineup of devices at a splashy Cupertino event. Leading the announcements was the iPhone 17
10 September 2025
 ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  · 
Miracle Cure, Mega-Deals & Vaccine Drama: Global Biotech & Health Roundup (Aug 13–14, 2025)

Miracle Cure, Mega-Deals & Vaccine Drama: Global Biotech & Health Roundup (Aug 13–14, 2025)

Breakthroughs in Biotech & Pharma Big Deals & Industry Moves Regulatory & Health Policy Updates Public Health Developments Noteworthy Medical Research Healthcare Technology & Innovation Sources: Official press releases, government health agency updates, and reputable media coverage were used in
14 August 2025
 ·  ·  ·  ·  ·  ·  · 
Top Biotechnology and Health Tech Trends in 2025: Mid-Year Update and Forecast (Updated: June 27th, 2025)

Top Biotechnology and Health Tech Trends in 2025: Mid-Year Update and Forecast (Updated: June 27th, 2025)

Late 2024, the first FDA-approved CRISPR-based therapy exagamglogene autotemcel (Casgevy) reached patients, with Vertex reporting $2 million in revenue from this sickle-cell gene-editing therapy in Q3 2024. Prime Medicine’s PM359 autologous CRISPR prime-edited cell therapy for chronic granulomatous disease began
27 June 2025
 ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  · 
Go toTop